| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 6 |
| 1 | POLYETHYLENE GLYCOL 3350 | 5 |
| 2 | BACLOFEN | 4 |
| 3 | FUROSEMIDE | 4 |
| 4 | OMEPRAZOLE MAGNESIUM | 4 |
| 5 | TADALAFIL | 4 |
| 6 | ADALIMUMAB | 3 |
| 7 | ECULIZUMAB | 3 |
| 8 | ERGOCALCIFEROL | 3 |
| 9 | HYDROMORPHONE HYDROCHLORIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL AND LEVONORGESTREL | 2 | 0.0010 |
| 1 | CICLOPIROX | 1 | 0.0004 |
| 2 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 2 | 0.0003 |
| 3 | ZANUBRUTINIB | 1 | 0.0002 |
| 4 | BUPIVACAINE | 2 | 0.0002 |
| 5 | OXCARBAZEPINE | 3 | 0.0002 |
| 6 | SENNOSIDES 8.6 MG TABLETS | 3 | 0.0001 |
| 7 | SENNA LEAF | 3 | 0.0001 |
| 8 | ERGOCALCIFEROL | 3 | 0.0001 |
| 9 | URSOSIOL | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Osmotic Laxative [EPC] | 7 |
| 1 | Prostacycline Vasodilator [EPC] | 6 |
| 2 | Estrogen [EPC] | 5 |
| 3 | Loop Diuretic [EPC] | 5 |
| 4 | Endothelin Receptor Antagonist [EPC] | 4 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 4 |
| 6 | Progestin [EPC] | 4 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 4 |
| 8 | Anti-epileptic Agent [EPC] | 3 |
| 9 | Benzodiazepine [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 3 | Bile Acid [EPC] | 2 | 0.0001 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 2 | 0.0001 |
| 5 | Complement Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 4 | 0.0000 |
| 8 | Prostacycline Vasodilator [EPC] | 6 | 0.0000 |
| 9 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |